Skip to main content

Epidemiology of malaria among pregnant women during their first antenatal clinic visit in the middle belt of Ghana: a cross sectional study

Abstract

Background

Malaria during pregnancy may result in unfavourable outcomes in both mothers and their foetuses. This study sought to document the current burden and factors associated with malaria and anaemia among pregnant women attending their first antenatal clinic visit in an area of Ghana with perennial malaria transmission.

Methods

A total of 1655 pregnant women aged 18 years and above with a gestational age of 13–22 weeks, who attended an antenatal care (ANC) clinic for the first time, were consented and enrolled into the study. A structured questionnaire was used to collect socio-demographic and obstetric data and information on use of malaria preventive measures. Venous blood (2 mL) was collected before sulfadoxine-pyrimethamine administration. Malaria parasitaemia and haemoglobin concentration were determined using microscopy and an automated haematology analyser, respectively. Data analysis was carried out using Stata 14.

Results

Mean age (SD) and gestational age (SD) of women at enrolment were 27.4 (6.2) years and 16.7 (4.3) weeks, respectively. Overall malaria parasite prevalence was 20.4% (95% CI 18.5–22.4%). Geometric mean parasite density was 442 parasites/µL (95% CI 380–515). Among women with parasitaemia, the proportion of very low (1–199 parasites/µL), low (200–999 parasites/µL), medium (1000–9999 parasites/µL) and high (≥ 10,000 parasites/µL) parasite density were 31.1, 47.0, 18.9, and 3.0%, respectively. Age ≥ 25 years (OR 0.57, 95% CI 0.41–0.79), multigravid (OR 0.50, 95% CI 0.33–0.74), educated to high school level or above (OR 0.53, 95% CI 0.33–0.83) and in household with higher socio-economic status (OR 0.34, 95% CI 0.21–0.54) were associated with a lower risk of malaria parasitaemia. The prevalence of anaemia (< 11.0 g/dL) was 56.0%, and the mean haemoglobin concentration in women with or without parasitaemia was 9.9 g/dL or 10.9 g/dL, respectively.

Conclusion

One out of five pregnant women attending their first ANC clinic visit in an area of perennial malaria transmission in the middle belt of Ghana had Plasmodium falciparum infection. Majority of the infections were below 1000 parasites/µL and with associated anaemia. There is a need to strengthen existing malaria prevention strategies to prevent unfavourable maternal and fetal birth outcomes in this population.

Background

Despite efforts aimed at controlling and eliminating malaria, the disease still remains a major public health problem. It was estimated that 228 million cases of malaria occurred worldwide in 2018 (decreased from 231 million cases in 2017), and that there were 405,000 deaths in 2018 compared to 416,000 in 2017. Most malaria cases (93%) and deaths (94%) occurred in the World Health Organization (WHO) Africa Region, with Plasmodium falciparum accounting for 99.7% of the cases [1]. Children under 5 years of age and pregnant women are the most at risk of malaria infection [2, 3]. In sub-Saharan Africa where moderate to high transmission of malaria occurs, an estimated 11 million out of 38 million (29%) pregnancies were exposed to malaria in 2018 [1]. Although often asymptomatic, P. falciparum infection in pregnancy is associated with unfavourable pregnancy outcomes such as stillbirth, low birth weight (LBW), pre-term delivery, abortion and maternal anaemia [4,5,6]. Prevalence of malaria in pregnant women peaks in the second trimester. Malaria in pregnancy is also a useful marker for malaria surveillance at community level [7, 8] with common risk factors being a primagravida and being young [2, 9, 10].

As the burden of malaria varies in different geographical locations and population groups, surveillance of malaria cases has been recommended by WHO to identify areas or population groups most affected by malaria so that the necessary resources and interventions can be targeted at these groups [11], and their impact monitored and evaluated [12]. The general epidemiology of malaria has been comprehensively described for different age groups in the area of Ghana in which this study was undertaken [13] but information on the characteristics of malaria in pregnant women is sparse.

This study aimed at describing the prevalence and risk factors for malaria and anaemia among pregnant women living in an area of high malaria transmission in the middle belt of Ghana, prior to administration of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP).

Methods

Study area

This study was conducted in four adjoining administrative areas, the Kintampo North Municipality, Kintampo South District, Nkoranza South Municipality, and Nkoranza North District, located in the Bono East Region, within the forest-savannah, transitional ecological zone in the middle belt of Ghana (Fig. 1). The Kintampo districts have a surface area of 7162 sq km, an approximate resident population of 150,000 and 4000 births per year [14]. Mean monthly temperature ranges from 18 to 38 °C while rainfall averages 1250 mm per annum. The main vectors for transmission of malaria are Anopheles gambiae and Anopheles funestus and the transmission is perennial, but peaks between April and October. The annual entomological inoculation rate was 269 infective bites per person per year in 2005 [13, 15], but is currently likely to be less. The Nkoranza districts have an approximate surface area of 2400 sq km and resident population of 130,000.

Fig. 1
figure1

Map showing the study areas in the middle belt of Ghana

Study design

This was an analysis of baseline data collected from pregnant women enrolled into a cohort study evaluating the effectiveness and safety of four or more doses of IPTp-SP. Eligibility criteria included pregnant women of any gravidity who attended the antenatal care (ANC) clinic for the first time, who had a gestational age 13–22 weeks, were aged 18 years or above, were known negative for human immunodeficiency virus (HIV) infection, and were willing to participate in the study (demonstrated by signing or thumb-printing an informed consent form).

Enrolment of participants

Enrolment of study participants was done at ANC clinics within the study area from July 2017 to March 2019. A general introduction on the nature of the study was given to the pregnant women by the nursing staff at the ANC during their health talks. An initial screening was done to determine eligibility. For those meeting the inclusion criteria, a member of the study team then explained the study further including what an informed consent is, why the study was being done, what it involved in terms of benefits, risks, compensation, confidentiality, right to refuse to be part of the study, and the right to still receive all routine ANC services. Following collection of informed consent, eligible study participants had a questionnaire completed which included information on demographics, obstetric history, socio-economic status (SES), malaria symptoms, anti-malarial drug use, insecticide-treated bed net (ITN) use, and use of other malaria vector preventive measures.

Sample collection

Prior to commencement of IPTp-SP, a blood sample (2 mL) was collected by a trained member of the study team using sterile venepuncture and transferred into a K2-EDTA tube (BD, Berkshire, UK) for a full blood count. Samples were kept in a transport box containing cold packs and transported to the laboratory in Kintampo for analysis.

Haematological analysis

Haemoglobin estimations were performed using K2-EDTA anticoagulated blood on a validated and calibrated Horiba-ABX Micros 60 or Pentra 60 C+ haematology analyser (Horiba-ABX, Montpellier, France) within 8 h of blood draw in the Haematology Unit of the Kintampo Health Research Centre (KHRC) Clinical Laboratory. In addition to regular user maintenance, routine servicing of the analysers was performed quarterly. Three levels of quality control samples (low, normal and high) were tested daily prior to analysis of study samples to ensure the reliability of results. The laboratory also participated in monthly external quality assessment schemes organized by the UK National External Quality Assessment Scheme (UK NEQAS, Watford, UK).

Malaria microscopy

Preparation and reading of malaria blood slides was done in the Parasitology Unit of KHRC Clinical Laboratory, as described by Swysen et al. [16] and WHO guidelines for preparation, staining and reading of malaria blood slides were followed [17]. Briefly, 6 µL and 2 µL of blood was used to prepare a thick smear and a thin smear, respectively, on the same slide using a template and the smears were then air-dried. Thin smears were fixed with absolute methanol, allowed to air-dry and both thick and thin smears were stained with 10% Giemsa stain (BDH Laboratory Supplies, Poole, Dorset, UK) in phosphate-buffered water (pH 7.2) for 10 min. Stained smears were air-dried and thick films were examined using an Olympus CX21 Microscope (Olympus, Tokyo, Japan) with × 10 eyepieces and ×100 oil immersion objectives to determine the presence, species and stages of any parasites that were present. The thin smear was used for confirming species and counting of parasites if more than 100 parasites were seen in the first field in the thick smear. Parasite density (parasites per µL of blood) was calculated using participants’ white blood cell (WBC) or red blood cell (RBC) count determined on an automated haematology analyser. A minimum of 100 fields were examined before a slide was recorded as negative. Each slide was independently examined by two microscopists who were certified by South Africa’s National Institute for Communicable Diseases (NICD) and/or the World Health Organization. The final result was determined as described by Swysen et al. [16]. As part of quality assurance, each batch of the 10% Giemsa stain was quality controlled by staining a known positive and negative smear prior to staining smears of study participants. Only certified malaria microscopists were allowed to read and report results for the study.

Sample size calculation

A total of 1655 pregnant women who were enrolled in the main study designed to evaluate the impact of four or more doses of SP on placental malaria, LBW and anaemia were included in this cross-sectional study. With a malaria prevalence of 17.6% reported among pregnant women at outpatient departments (OPDs) in Ghana by the National Malaria Control Programme [18], the study estimated the prevalence of malaria with a precision of 1.8%.

Outcome definitions

Clinical malaria was defined as parasitaemia and an axillary temperature ≥ 37.5 °C or a history of fever within the past 48 h, while asymptomatic malaria was defined as any level of parasitaemia without fever. The level of parasitaemia was classified as very low (1–199 parasites/µL), low (200–999 parasites/μL), medium (1000–10,000 parasites/μL), and high (> 10,000 parasites/μL) after modification of published cut-offs to create the very low category [19, 20]. Anaemia was defined as a haemoglobin concentration < 11.0 g/dL, and sub-divided as severe (< 7.0 g/dL), moderate (7.0–9.9 g/dL), and mild (10.0–10.9 g/dL) [21]. ITN use was defined as sleeping under a net the previous night, and use of other malaria vector preventive measures defined as usage within the past 7 days.

Data management and statistical analysis

Enrolment, haematology and parasitology data were entered into pre-coded questionnaires and checked for completeness. Completed questionnaires were double-entered and verified using a database designed with CSharp application as front end and SQL Server as back end. Data processing and statistical analysis were carried out using Stata 14 (StataCorp, College Station, USA). Principal components analysis (PCA) was used to derive a wealth index variable (SES) based on each woman’s household assets and characteristics. Socio-demographic, obstetric and malaria vector prevention characteristics of all women enrolled in the study were summarized.

Wilcoxon rank-sum test was used to assess the association between parasite density and age (< 25 or ≥ 25) and gestational age (< 18 weeks or ≥ 18 weeks). The association of gravidity (primagravid, secundigravid, or multigravid) with parasite density was explored using Kruskal–Wallis test. The prevalence of malaria parasitaemia was computed together with its 95% confidence interval. Univariate and multivariate logistic regression was used to study the association between socio-demographic, obstetric and malaria vector prevention characteristics and the risk of malaria parasitaemia. Variables in the univariate analysis with a p-value < 0.15 were included in a multivariate logistic regression model. The interaction of age and gravidity on the risk of malaria parasitaemia was also explored.

Haemoglobin concentration in participants who had malaria parasitaemia was compared to those who did not have malaria parasitaemia using Wilcoxon rank-sum test. The prevalence of anaemia was further classified into mild, moderate and severe, and reported with 95% confidence intervals. Univariate and multivariate logistic regression was used to assess the association of socio-demographic, obstetric and malaria vector prevention characteristics of study participants with the risk of anaemia. Similar to the approach used in the analysis of malaria parasitaemia, variables from the univariate analysis with a p-value < 0.15 were included in a multivariate logistic regression model. The interaction of age and gravidity on the risk of anaemia was also explored. In all multivariate models, significance was established at a 5% level.

Results

Socio-demographic, obstetric, clinical, and malaria vector prevention characteristics of study participants at enrolment

A total of 1655 participants were eligible for inclusion in the study. Malaria microscopy results were available for 1647 (99.5%) participants, while haemoglobin results were available for 1465 participants (88.5%); samples from 182 were not adequate for haemoglobin estimation. Mean age (± SD) of the participants was 27.4 (± 6.2) years, with nearly half (49.6%) of them aged 25–34 years and the mean gestational age at enrolment (± SD) was 16.7 (± 4.3) weeks, with about two-thirds (67.4%) of women having a gestational age ≤ 18 weeks. Primigravidae and secundigravidae formed 21.0% (n = 355) and 23.7% (n = 392) of the participants, respectively. About one-fifth, 20.9% (n = 346) had completed high school or higher education.

Almost 90.0% (1488/1655) of participants reported possessing an ITN, of which 12.1% (180/1488) were reported torn. Reported ITN use among all women and those possessing an ITN was 66.2% (1095/1655) and 73.6% (1095/1488), respectively. About one-fifth of the participants reported using a mosquito coil within the last 7 days (Table 1). The main clinical complaints at enrolment were abdominal pain (7.9%, n = 131), bodily pains (7.9%, n = 130), loss of appetite (6.6%, n = 109), fever (6.2%, n = 106), drowsiness (4.8%, n = 80), vomiting (4.6%, n = 76), and nausea (4.2%, n = 69).

Table 1 Socio-demographic characteristics of pregnant women at enrolment

Malaria prevalence, species and density

Overall prevalence of malaria parasitaemia was 20.4% (95% CI 18.5–22.4%) and the prevalence of clinical malaria was 1.5% (95% CI 1.0–2.2%). The prevalence of parasitaemia was higher in women aged < 25 years (31.2%; 95% CI 27.6–35.0%) compared to those ≥ 25 years (14.5%, 95% CI 12.5–16.8%), and also higher in primigravidae (31.0%, CI 26.4–36.0%) compared to multigravidae (15.1%, 95% CI 12.9–17.6%). Plasmodium falciparum was the only species identified among the Plasmodium isolates. Overall geometric mean parasite density (GMPD) was 442 parasites per µL (95% CI 380–515). Density was also higher in women aged < 25 years (628 parasites per µL, 95% CI 511–772) compared to those ≥ 25 years (293 parasites per µL, 95% CI 238–362), and in primigravidae (721 parasites per µL, 95% CI 554–938) compared with multigravidae (295 parasites per µL, 95% CI 234–372) (Table 2). Among pregnant women with malaria parasites, more than three-quarters had parasite density below 1000 parasites/µL of blood. The proportion of women with very low, low, medium, and high density parasitaemia were 31.1% (95% CI 26.3–36.2%), 47.0% (95% CI 41.7–52.4%), 18.9% (95% CI 15.1–23.5%), and 3.0% (95% CI 1.6–5.4%), respectively.

Table 2 Malaria prevalence and geometric mean parasite density by age, gestational age, gravidity, and enrolment location

Factors associated with malaria parasitaemia

In the unadjusted analyses, age, education, household SES, marital status, profession, gravidity, and ITN use were associated with risk of malaria parasitaemia (Table 3). In the multivariate analysis, women who reported using an ITN were 1.43 times likely to have parasitaemia compared to those who did not. Women ≥ 25 years of age were 0.57 times less likely than those < 25 years of age, multigravidae were 0.50 times less likely compared to primagravidae, traders or food sellers were 0.67 times less likely than women with no profession, women educated to high school or above were 0.53 times less likely compared to those with no education and the least poor were 0.34 times less likely compared to the most poor to have malaria parasitaemia (Table 3).

Table 3 Factors associated with malaria parasitaemia at first antenatal clinic attendance in the middle belt of Ghana

Effect of the interaction between age and gravidity on the prevalence of malaria parasitaemia

Figure 2 shows the effect of the interaction between age and gravidity on the prevalence of malaria parasitaemia. Prevalence was highest (33.2%) in primi- or secundigravidae aged < 25 years old and lowest (14.1%) in multigravidae aged ≥ 25 years. Compared to multigravidae aged ≥ 25 years, malaria parasataemia prevalence was 3.04 times higher (95% CI 2.31–4.01, p < 0.001) in primigravidae aged < 25 years and 1.89 times higher (95% CI 1.16–3.08, p = 0.011) in those ≥ 25 years, respectively. There was, however, no significant difference between multigravid women aged < 25 years and those ≥ 25 years (OR 1.17; 95% CI 0.80–1.71, p = 0.424).

Fig. 2
figure2

Effect of interaction between age and gravidity on prevalence of malaria parasitaemia

Prevalence of anaemia among pregnant women

Mean (± SE) haemoglobin concentration for the pregnant women at first ANC visit was 10.7 g/dL (± 0.04). Among women with malaria parasitaemia, mean haemoglobin concentration was significantly lower than in those without malaria parasitaemia (9.9 g/dL vs 10.9 g/dL; p-value < 0.001) (Fig. 3). Overall prevalence of anaemia (haemoglobin < 11.0 g/dL) and severe anaemia (haemoglobin < 7.0 g/dL) were 56.0% (95% CI 53.4–58.5%) and 1.4% (95% CI 0.9–2.2%), respectively (Table 4).

Fig. 3
figure3

Haemoglobin concentration by malaria parasitaemia status

Table 4 Prevalence of different degrees of anaemia among pregnant women in the middle belt of Ghana

Factors associated with anaemia among pregnant women

In the univariate analysis, age, gestational age, education, household SES, marital status, profession, gravidity, and malaria parasitaemia status were associated with risk of anaemia (Table 5). In the multivariate logistic regression analysis, the risk of anaemia was 0.61 times lower in multigravidae compared to primagravidae. Women with gestational age ≥18 weeks were 2.24 times more likely to have anaemia compared to those aged < 18 weeks, and unmarried women were 1.44 times likely to be anaemic compared to the married women. Women who had parasitaemia up to 999 parasites/µL were 3.49 times likely to have anaemia, whiles those with parasitaemia ≥ 1000 parasites/µL were 4.05 times more likely to have anaemia, compared to those without parasitaemia (Table 5).

Table 5 Factors associated with anaemia at first antenatal clinic attendance in the study area

Interaction between age and gravidity on prevalence of anaemia among pregnant women

The effect of the interaction between age and gravidity on prevalence of anaemia is shown in Fig. 4. Prevalence of any anaemia was highest (66.2%) in primi- or secundigravidae aged < 25 years and least (50.0%) in multigravid pregnant women aged ≥ 25 years. Compared to multigravid pregnant women aged ≥ 25 years, anaemia prevalence was significantly higher (p < 0.001) in primi- or secundigravidae aged < 25 years (COR 1.96; 95% CI 1.53–2.51). There was no significant difference in the prevalence of anaemia between multigravidae < 25 years and ≥ 25 years.

Fig. 4
figure4

Effect of interaction between age and gravidity on prevalence of anaemia

Discussion

This study observed a high prevalence of malaria parasitaemia among pregnant women during their first ANC visit in the middle belt of Ghana where malaria transmission is high and perennial. The overall malaria parasitaemia prevalence in this study population (20.4%) is similar to that reported from Hohoe municipality in Ghana (20.3%) but is much higher than that reported from other sites in Ghana: Madina, Accra (5.0%) [22] and Ejisu Buabeng and Sekyere East Districts (10.7%) [23]. The prevalence of parasitaemia seen in the study area is comparable to that reported from elsewhere in Africa: 22.4% in Mount Cameron, Cameroon [24], 19.6% in Blantyre, Malawi [25] and in Mali [10], however, there were reports of higher prevalence of parasitaemia in Nchelenge, Zambia (31.8%) [2] and Navrongo, Ghana (42.0%) [10], respectively. Prevalence of clinical malaria reported in this study (1.5%) was lower compared to findings reported in Malawi [25] and Cameroon [24]. The marked variation in malaria prevalence across the various studies is likely to be due to differences in malaria transmission intensity, malaria prevention measures used, rainfall, and environmental conditions [26, 27]. Finding higher malaria parasitaemia prevalence in younger primigravidae, which decreased with increasing age and gravidity, is consistent with several other studies [10, 27, 28].

The overall GMPD reported in this study (442 parasites/µL) is similar to that among pregnant women in Mount Cameroon, Cameroon [24], but much lower than that reported by other authors [2, 28]. This could be due to differences in transmission intensities and different levels of immunity in different locations. It could also partly be due to the use of participants’ own absolute WBC counts in this study rather than the assumed WBC count of 8000 per µL of blood, which was used in many of these studies in calculating parasite density. The use of assumed 8000 WBCs per µL of blood has been reported to result in overestimation of malaria parasite density several-fold among pregnant women [29] and children [30]. Although only P. falciparum was detected using microscopy in this study, this is not surprising. The use of the PCR technique may have resulted in detection of other species, as a study of non-falciparum malaria in northern Ghana showed a prevalence of 0.96% [31]. The findings in this study also indicated that the risk of malaria parasitaemia was higher in women in their first pregnancy, younger women, or those of lower SES or education. These observations are consistent with other published studies in Gabon [32], Ghana [10, 28] and Zambia [2],

Surprisingly, this study found reported ITN use to be associated with higher risk of malaria parasitaemia in multivariate analysis, which is contrary to what has been reported in many studies [33, 34] where regular use of ITN by pregnant women was associated with protection against malaria. The finding on ITN use in this study is, however, consistent with a report from Navrongo, Ghana [10]. This observation, however, does not suggest ITN use does not protect against malaria. The state of the ITN used would also need to be taken into consideration, as about 12% of participants in this study reported the nets in which they slept were torn. Current ITN use could also be a marker of a person living in an area with high mosquito biting rates making them more likely to use an ITN than a person living in an area where mosquito bites and malaria were infrequent. [10].

The findings on the overall prevalence of anaemia among pregnant women in this study is higher than that reported from the Sunyani Municipality of Ghana [35], similar to that from Cameroon (53.4%) [36], but much lower than that reported from other districts in Ghana: 64.8% [37] and 70.0% [28], and Nigeria (71.3%) [38]. The factors strongly associated with anaemia in this study (i.e., being primagravid, gestational age at first ANC visit, having malaria parasitaemia) are similar to those reported in many other studies in different geographical locations [28, 35, 38].

The strength of this study is that it is adequately powered to provide accurate information on the high prevalence of malaria in pregnant women in the study area and the need for effective measures of control and for monitoring their progress. The study, however, has some limitations. Firstly, malaria microscopy has been shown to underestimate malaria parasite prevalence compared to molecular methods due to the presence of sub-microscopic levels of parasitaemia. However, quality-assured malaria microscopy remains the gold standard for diagnosis and surveillance. Strict adherence to standard operating procedures was ensured and internationally certified microscopists used for the reading of malaria slides. Secondly, although helminth infections haemoglobinopathies have been identified as important risk factors of anaemia, stool examination and haemoglobin genotyping could not be performed during this study.

Conclusions

The prevalence of P. falciparum infection during a first ANC visit in the middle belt of Ghana is high, with one out of five women infected and one out of three first-time pregnant women aged < 25 years infected. More than three-quarters of these infections were below 999 parasites/µL of blood. There is the need to strengthen existing malaria prevention strategies and also to employ targeted interventions to control malaria in the study area. This study provides indicators for regular monitoring of progress made towards malaria control or elimination.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ANC:

Antenatal care

AOR:

Adjusted odds ratio

CI:

Confidence interval

COR:

Crude odds ratio

GMPD:

Geometric mean parasite density

HH:

Household

IPTp:

Intermittent preventive treatment during pregnancy

ITN:

Insecticide-treated bednet

K2-EDTA:

Di-potassium ethylenediaminetetraacetic acid

KHRC:

Kintampo Health Research Centre

LBW:

Low birth weight

NICD:

National Institute for Communicable Diseases

OPD:

Out-Patient Department

PCA:

Principal component analysis

RBC:

Red blood cell

SD:

Standard deviation

SES:

Socio-economic status

SP:

Sulphadoxine-pyrimethamine

UK NEQAS:

United Kingdom National External Quality assessment Scheme

WBC:

White blood cell

WHO:

World Health Organization

References

  1. 1.

    WHO. World malaria report 2019. Geneva: World Health Organization; 2019.

    Google Scholar 

  2. 2.

    Chaponda EB, Chandramohan D, Michelo C, Mharakurwa S, Chipeta J, Chico RM. High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study. Malar J. 2015;14:380.

    Article  Google Scholar 

  3. 3.

    van Eijk AM, Hill J, Noor AM, Snow RW, ter Kuile FO. Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2015;3:e617–28.

    Article  Google Scholar 

  4. 4.

    Briand V, Cottrell G, Massougbodji A, Cot M. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J. 2007;6:160.

    Article  Google Scholar 

  5. 5.

    Valea I, Tinto H, Drabo MK, Huybregts L, Henry M-C, Roberfroid D, et al. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes. Malar J. 2010;9:324.

    Article  Google Scholar 

  6. 6.

    Tutu EO, Lawson B, Browne E. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana. Malar J. 2011;10:385.

    CAS  Article  Google Scholar 

  7. 7.

    Brunner NC, Chacky F, Mandike R, Mohamed A, Runge M, Thawer SG, et al. The potential of pregnant women as a sentinel population for malaria surveillance. Malar J. 2019;18:370.

    Article  Google Scholar 

  8. 8.

    Willilo RA, Molteni F, Mandike R, Mugalura FE, Mutafungwa A, Thadeo A, et al. Pregnant women and infants as sentinel populations to monitor prevalence of malaria: results of pilot study in Lake Zone of Tanzania. Malar J. 2016;15:392.

    Article  Google Scholar 

  9. 9.

    Martínez-Pérez G, Lansana DP, Omeonga S, Gupta H, Breeze-Barry B, González R, Bardají A, et al. Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia. Malar J. 2018;17:357.

    Article  Google Scholar 

  10. 10.

    Berry I, Walker P, Tagbor H, Bojang K, Coulibaly SO, Kayentao K, et al. Seasonal dynamics of malaria in pregnancy in West Africa: evidence for carriage of infections acquired before pregnancy until first contact with antenatal care. Am J Trop Med Hyg. 2018;98:534–42.

    Article  Google Scholar 

  11. 11.

    WHO. World malaria report 2018. Geneva: World Health Organization; 2018.

    Google Scholar 

  12. 12.

    WHO. Malaria surveillance, monitoring & evaluation: a reference manual. Geneva: World Health Organization; 2018.

    Google Scholar 

  13. 13.

    Owusu-Agyei S, Asante KP, Adjuik M, Adjei G, Awini E, Adams M, et al. Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J. 2009;8:220.

    Article  Google Scholar 

  14. 14.

    Owusu-Agyei S, Nettey OE, Zandoh C, Sulemana A, Adda R, Amenga-Etego S, Mbacke C. Demographic patterns and trends in Central Ghana: baseline indicators from the Kintampo Health and Demographic Surveillance System. Glob Health Action. 2012;5:1–11.

    Article  Google Scholar 

  15. 15.

    Dery DB, Brown C, Asante KP, Adams M, Dosoo D, Amenga-Etego S, et al. Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana. Malar J. 2010;9:314.

    Article  Google Scholar 

  16. 16.

    Swysen C, Vekemans J, Bruls M, Oyakhirome S, Drakeley C, Kremsner P, et al. Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J. 2011;10:223.

    Article  Google Scholar 

  17. 17.

    WHO. Basic malaria microscopy: Part I. Learner’s guide. Geneva: World Health Organization; 2010.

    Google Scholar 

  18. 18.

    GHS. Malaria in Pregnancy. Accra: Ghana Health Service; 2017.

    Google Scholar 

  19. 19.

    Noone C, Parkinson M, Dowling DJ, Aldridge A, Kirwan P, Molloy SF, et al. Plasma cytokines, chemokines and cellular immune responses in pre-school Nigerian children infected with Plasmodium falciparum. Malar J. 2013;12:5.

    CAS  Article  Google Scholar 

  20. 20.

    Izuka E, Ugwu E, Obi S, Ozumba B, Nwagha T, Obiora-Izuka C. Prevalence and predictors of placental malaria in human immunodeficiency virus-positive women in Nigeria. Niger J Clin Pract. 2017;20:31–6.

    CAS  Article  Google Scholar 

  21. 21.

    WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: World Health Organization; 2011.

    Google Scholar 

  22. 22.

    Stephens JK, Ofori MF, Quakyi IA, Wilson ML, Akanmori BD. Prevalence of peripheral blood parasitaemia, anaemia and low birthweight among pregnant women in a suburban area in coastal Ghana. Pan Afr Med J. 2014;17(Suppl 1):3.

    PubMed  PubMed Central  Google Scholar 

  23. 23.

    Ampofo GD, Tagbor H, Bates I. Effectiveness of pregnant women’s active participation in their antenatal care for the control of malaria and anaemia in pregnancy in Ghana: a cluster randomized controlled trial. Malar J. 2018;17:238.

    Article  Google Scholar 

  24. 24.

    Anchang-Kimbi JK, Nkweti VN, Ntonifor HN, Apinjoh TO, Tata RB, Chi HF, et al. Plasmodium falciparum parasitaemia and malaria among pregnant women at first clinic visit in the mount Cameroon Area. BMC Infect Dis. 2015;15:439.

    Article  Google Scholar 

  25. 25.

    Boudová S, Divala T, Mawindo P, Cohee L, Kalilani-Phiri L, Thesing P, et al. The prevalence of malaria at first antenatal visit in Blantyre, Malawi declined following a universal bed net campaign. Malar J. 2015;14:422.

    Article  Google Scholar 

  26. 26.

    Tegegne Y, Asmelash D, Ambachew S, Eshetie S, Addisu A, Jejaw Zeleke A. The prevalence of malaria among pregnant women in Ethiopia: a systematic review and meta-analysis. J Parasitol Res. 2019;2019:8396091.

    Article  Google Scholar 

  27. 27.

    Kweku M, Ofori M, Takramah W, Axame WK, Owusu R, Parbey P, et al. Prevalence of malaria and anaemia among pregnant women attending Antenatal Care Clinic in the Hohoe Municipality of Ghana. Int J Nurs Didactics. 2017;7:21–30.

    Google Scholar 

  28. 28.

    Clerk CA, Bruce J, Greenwood B, Chandramohan D. The epidemiology of malaria among pregnant women attending antenatal clinics in an area with intense and highly seasonal malaria transmission in northern Ghana. Trop Med Int Health. 2009;14:688–95.

    Article  Google Scholar 

  29. 29.

    Haggaz AD, Elbashir LM, Adam GK, Rayis DA, Adam I. Estimating malaria parasite density among pregnant women at central Sudan using actual and assumed white blood cell count. Malar J. 2014;13:6.

    Article  Google Scholar 

  30. 30.

    Jeremiah ZA, Uko EK. Comparative analysis of malaria parasite density using actual and assumed white blood cell counts. Ann Trop Paediatr. 2007;27:75–9.

    Article  Google Scholar 

  31. 31.

    Williams J, Njie F, Cairns M, Bojang K, Coulibaly SO, Kayentao K, et al. Non-falciparum malaria infections in pregnant women in West Africa. Malar J. 2016;15:53.

    Article  Google Scholar 

  32. 32.

    Jäckle MJ, Blumentrath CG, Zoleko RM, Akerey-Diop D, Mackanga J-R, Adegnika AA, et al. Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups. Malar J. 2013;12:412.

    Article  Google Scholar 

  33. 33.

    Ouma P, Van Eijk AM, Hamel MJ, Parise M, Ayisi JG, Otieno K, et al. Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya. Trop Med Int Health. 2007;12:1515–23.

    Article  Google Scholar 

  34. 34.

    Feleke DG, Adamu A, Gebreweld A, Tesfaye M, Demisiss W, Molla G. Asymptomatic malaria infection among pregnant women attending antenatal care in malaria endemic areas of North-Shoa, Ethiopia: a cross-sectional study. Malar J. 2020;19:1–6.

    Article  Google Scholar 

  35. 35.

    Anlaakuu P, Anto F. Anaemia in pregnancy and associated factors: a cross sectional study of antenatal attendants at the Sunyani Municipal Hospital, Ghana. BMC Res Notes. 2017;10:402.

    Article  Google Scholar 

  36. 36.

    Asoba G, Ndamukong K, Achidi A. Prevalence of malaria parasite infection in pregnant women in three towns of the South West Region of Cameroon. J Cameroon Acad Sci. 2009;8:71–7.

    Google Scholar 

  37. 37.

    Tagbor H, Cairns M, Bojang K, Coulibaly SO, Kayentao K, Williams J, et al. A non-inferiority, individually randomized trial of intermittent screening and treatment versus intermittent preventive treatment in the control of malaria in pregnancy. PLoS ONE. 2015;10:e0132247.

    Article  Google Scholar 

  38. 38.

    Dattijo L, Daru P, Umar N. Anaemia in pregnancy: prevalence and associated factors in Azare, North-East Nigeria. Int J Trop Dis Health. 2016;11:1–9.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the study participants for volunteering to participate in this study, the Health Management Teams of the Kintampo North Municipality and Kintampo South District, Managements of Kintampo Municipal Hospital, Kintampo South District Hospital, Yizura Hospital, Prince of Peace Maternity & Clinic and St. Theresa’s Hospital, Nkoranza who granted permission for this study, the Ghana Health Service, staff of the Kintampo Health Research Centre who supported the field work, laboratory analysis and data management, and Mr. Ken Wiru for providing the maps in this manuscript. The lead author is extremely grateful to the Management of the Kintampo Health Research Centre (KHRC) for funding this study, which forms part of his PhD thesis.

Funding

This study was supported by the Kintampo Health Research Centre, Ghana Health Service.

Author information

Affiliations

Authors

Contributions

DKD, SOA, DC, BG and KPA conceived the study. DKD designed the laboratory studies. DKD and DA coordinated participant enrolment & study coordination. DKD, LA, KK, DAG, and VA performed the laboratory analysis. MT, SAE and DKD managed and cleaned data for analysis. FBO, DKD and JB performed statistical analysis of the data. DKD wrote the first draft of the manuscript. All authors contributed to the interpretation of the results, and revision of the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to David Kwame Dosoo.

Ethics declarations

Ethics approval and consent to participate

The study protocol and instruments for this study were reviewed and approved by the ethics committees of the Kintampo Health Research Centre (KHRCIEC/2017-9) and the London School of Hygiene and Tropical Medicine (LSHTM Ethics Ref: 12336). Written informed consent was obtained from each eligible pregnant woman prior to commencement of study procedures.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dosoo, D.K., Chandramohan, D., Atibilla, D. et al. Epidemiology of malaria among pregnant women during their first antenatal clinic visit in the middle belt of Ghana: a cross sectional study. Malar J 19, 381 (2020). https://doi.org/10.1186/s12936-020-03457-5

Download citation

Keywords

  • Malaria parasitaemia
  • Anaemia
  • Prevalence
  • Risk factors
  • Antenatal clinic